Wageningen, Netherlands

Tomoyuki Furukawa

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Keygene N.v.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoyuki Furukawa. Retrieved from https://idiyas.com/inventor/tomoyuki-furukawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomoyuki Furukawa: Innovator in DNA Alteration Technology

Introduction

Tomoyuki Furukawa is a notable inventor based in Wageningen, Netherlands. He has made significant contributions to the field of genetic engineering, particularly in the targeted alteration of DNA. His innovative approach utilizes oligonucleotides to achieve precise modifications in DNA sequences.

Latest Patents

Furukawa holds a patent for a method titled "Targeted alteration of DNA with oligonucleotides." This invention relates to a technique for the targeted alteration of acceptor DNA, specifically duplex acceptor DNA. The method involves the use of at least two oligonucleotides, each containing at least one mismatch relative to the targeted acceptor DNA. The mismatches are strategically positioned to enhance the accuracy of the DNA alteration process. This patent represents a significant advancement in genetic engineering, with potential applications in various biotechnological fields.

Career Highlights

Furukawa is associated with Keygene N.V., a company known for its innovative research in plant biotechnology. His work at Keygene has allowed him to explore and develop cutting-edge technologies that contribute to advancements in genetic research and applications.

Collaborations

Furukawa collaborates with Michiel Theodoor Jan De Both, further enhancing the research and development efforts at Keygene. Their combined expertise fosters innovation and drives the company's mission to improve agricultural practices through biotechnology.

Conclusion

Tomoyuki Furukawa's contributions to DNA alteration technology exemplify the impact of innovative thinking in the field of genetics. His patent and work at Keygene highlight the importance of collaboration and research in advancing biotechnological solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…